Institut De Cancérologie De Lorraine
Clinical trials sponsored by Institut De Cancérologie De Lorraine, explained in plain language.
-
New microscope could spot cancer cells Mid-Surgery
Diagnosis OngoingThis study tests a special microscope that helps surgeons see if any cancer cells are left behind during skin cancer removal. About 42 adults with head, neck, or skin cancer will take part. The goal is to see if this microscope works as well as standard lab tests to guide surgery…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Diagnosis
Last updated May 26, 2026 04:15 UTC
-
New program aims to stop chemo brain before it starts
Symptom relief OngoingThis study looks at whether a personalized support program led by a nurse can help prevent memory and thinking problems (often called 'chemo brain') in women with non-metastatic breast cancer who are about to start chemotherapy. Fifty women will receive 9 months of follow-up with…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Symptom relief
Last updated May 26, 2026 04:13 UTC
-
Blood test could predict melanoma treatment failure early
Knowledge-focused OngoingThis study looks at whether a simple blood test can help doctors track melanoma and spot when a treatment stops working. About 136 adults with stage IIB to IV melanoma will give blood samples over time. The goal is to see if changes in tumor DNA in the blood can predict the need …
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 26, 2026 03:57 UTC
-
Blood test may predict ovarian cancer relapse without surgery
Knowledge-focused OngoingThis study tests whether a blood test (liquid biopsy) can be used instead of multiple tissue samples to see how ovarian cancer changes over time. Twenty newly diagnosed patients will give blood and tissue samples during their treatment for up to 2 years. The goal is to see if the…
Phase: NA • Sponsor: Institut de Cancérologie de Lorraine • Aim: Knowledge-focused
Last updated May 04, 2026 16:31 UTC